NSE filing, NSE: NIITLTD. Summary written from the filing by ALFA Finder's alert engine.
NIIT Ltd: key numbers
- Share price
- ₹69.52
- Market cap
- ₹952.4 Cr
- Revenue (annual)
- ₹390.2 Cr
- Net profit (annual)
- ₹5.28 Cr
- P/E (TTM)
- 175.4×Sector 22.9×
- Promoter holding
- 41.78%+0.91% QoQ
- FII holding
- 8.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NIIT Ltd
All →NIIT Earnings Call Transcript: Key Takeaways
Revenue fell 6% YoY due to sharp spending pullbacks by Global System Integrator (GSI) clients, masking 17% growth in the banking segment.
NIIT Other Announcement
NIIT's board recommended Price Waterhouse as statutory auditor for five years from the 2027 AGM. Shareholder approval is pending; the incumbent continues until then.
NIIT Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 982 Mn, down 6% YoY, up 3% QoQ. EBITDA INR 27 Mn; PAT loss INR 22 Mn. AI revenue 12.4% of total.
NIIT Results Update
NIIT Limited released its Q2 FY27 results press release, reporting revenue growth and EBITDA doubling year-on-year. AI offerings reached 12.4% of revenue, and a new CEO was appointed.
NIIT Q2 FY27 Results: Net Loss of ₹1.8 Cr
NIIT Ltd reported revenue from operations of ₹98.2 Cr (-6.4% YoY) and a net loss of ₹1.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹1.8 Cr
NIIT Board Meeting Date
NIIT Limited scheduled a board meeting for October 27, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter ended September 30, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.